Larvol Delta - Soquelitinib-vs-Standard-of-Care-in-Participants-With-RelapsedRefractory-Peripheral-Tcell-Lymphoma-Not-Otherwise-Specified-Follicular-Helper-Tcell-Lymphomas-or-Systemic-Anaplastic-Largecell-Lymphoma

Folotyn (pralatrexate) - Aurobindo

soquelitinib (CPI-818) - Corvus Pharma

Beleodaq (belinostat) - Aurobindo, Assertio

http://clinicaltrials.gov/ct2/show/NCT06561048

Apr 9, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next